Allē

61
Allē is an Android app from AbbVie in the Medical category, currently rated 4.5★ across 1,796 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 61: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Medical complexity ×1.55 | +$27K |
| 🌐 Cross-platform reach (iOS + Android) | +$43K |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Below median · 53/100MID TIERunderperforming peers- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.52★ across 1,796 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Excellent rating (4.5★)METRIC | +$2,200 | |
| Low install base (1,796 ratings)METRIC | +$1,500 | |
| Mature app (9y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Allē
- Developer
- AbbVie
- Bundle ID
- com.allergan.bd.bdmobileapp
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.allergan.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $172/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth1,796 ratings+52% lifetimeShow 3-year history estimate ▾
📝 About this app
With Allē, you can earn and save on aesthetic products and treatments at your participating provider.
Allē’s app gives you access to all that Allē offers, including Allē Flash, which enables you to scan for a surprise offer while at your provider’s office.
Simply log in to your Allē Account within the app and you’re all set. Or, download the app and create a new account in a few simple steps.
Now, let’s see what’s inside.… View full description on the official store →
Tech & Domain Intel — allergan.com
- Tech stack
- Microsoft 365 · Loom · Atlassian (Jira/Confluence)
Track this app’s revenue
FREE📝 Description
95
More by AbbVie
View all →Why medium confidence: 1,796 ratings · no founder-verified revenue (model estimate only).




